Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

CHU Saint Pierre

Belgium Hoogstraat 322, 1000 Brussels, Belgium

About the sponsor

Clinical research at CHU Saint Pierre includes work in COPD, with attention to small-airway disease and inhaled treatment strategies relevant to chronic respiratory impairment.

  • Chronic Obstructive Pulmonary Disease
  • Small-airway disease
  • Inhaled corticosteroid therapy

The respiratory portfolio reflects interest in symptom control and airway-focused treatment effects in adults with persistent lung disease.

About Specializations

CHU Saint Pierre runs clinical trials in conditions such as Sickle cell anaemia with crisis, Sickle cell anaemia, Sickle cell disease, Spinal fusion surgery, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Sickle cell anaemia with crisis+2

Recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Lidocaine Hydrochloride
  • Sponsor:CHU Saint Pierre

Spinal fusion surgery

Not yet recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Ketamine
  • Sponsor:CHU Saint Pierre

HIV infection

Not yet recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
  • Sponsor:CHU Saint Pierre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.